Press release
Adrenocortical Carcinoma Treatment Market: Segment Snapshot and Table of Content (2017 - 2025)
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment.View Report Preview @ https://www.persistencemarketresearch.com/market-research/adrenocortical-carcinoma-treatment-market.asp
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
Detection of tumors at an early clinical stage is crucial for curative resection; total resection offers the only prospect of cure. The estimated overall five-year survival rate for patients with adrenocortical carcinoma is approximately 20-35%. For cases in which total surgical resection is achieved, this rate is estimated to be approximately 32-47%, while in cases in which total surgical extirpation has not been possible, the five-year survival rate is estimated to be 10-30%.
Although it mainly occurs in adults, children are also affected by adrenocortical carcinoma. Based on data from the International Pediatric Adrenocortical Tumor Registry, the median age at which children develop adrenal carcinomas is 3.2 years. 60% are younger than four years, and 14% are older than 13 years. Historically, only about 30% of these malignancies are confined to the adrenal gland at the time of diagnosis. However, recently, more adrenocortical carcinoma cases have been diagnosed in early states, most likely due to the widespread use of high-quality imaging techniques. The female-to-male ratio for adrenocortical carcinoma is approximately 2.5-3:1. The accumulation of data, especially in international registries, revealed the incidence of adrenal tumors to be higher in female individuals than had previously been thought, particularly in those aged 0-3 years and those over 13 years. Nonfunctional adrenocortical carcinomas are distributed equally between the sexes.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/16918
Regionally, the market can be segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America and Europe dominate the global adrenocortical carcinoma treatment market. The U.S. represents the largest market for adrenocortical cancer followed by which is Canada. In Europe, France, Germany and the U.K. holds the major share of adrenocortical cancer treatment. However, Asia is expected to show high growth rates in the next five years in global adrenocortical carcinoma treatment market. Japan, China, and India are expected to be the fastest-growing markets in Asia.
Some of the players of adrenocortical carcinoma treatment market include ArQule, Inc., EnGeneIC Ltd., Exelixis, Inc., Merck KGA, Millendo Therapeutics, and Orphagen Pharmaceuticals, Inc. Some of the latest trends that have been observed in this market include companies involved in partnerships and R&D for more efficient technologies.
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/16918
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenocortical Carcinoma Treatment Market: Segment Snapshot and Table of Content (2017 - 2025) here
News-ID: 855573 • Views: …
More Releases from Persistence Market Research

Eyewear Packaging Market Projected to Generate Sales of USD 6.19 Bn by 2032 - Pe …
Eyewear Packaging Market Overview and Growth Insights
The global eyewear packaging market is witnessing robust growth, driven by surging demand for premium and protective packaging solutions across the eyewear industry. Valued at US$ 4.09 Bn in 2025, the market is expected to reach US$ 6.19 Bn by 2032, growing at a CAGR of 6.1% from 2025 to 2032. As eyewear becomes increasingly personalized and style-conscious, the need for tailored packaging solutions…

High Speed Steel (HSS) Metal Cutting Tools Market Anticipated to Explode in Grow …
Introduction
Tooling is an essential component of the manufacturing process, enabling industries to shape, cut, form, bore, grind, and mill materials with precision. High Speed Steel (HSS) metal cutting tools play a vital role in achieving performance and efficiency across sectors such as automotive, construction, and industrial equipment. These tools are designed for durability, superior edge retention, and cost-effectiveness, making them indispensable for high-speed machining operations. As industries shift their focus…

E-Bike Motors Market Poised for Strong Surge by 2032 - Persistence Market Resear …
Overview of the E-Bike Motors Market
The E-Bike Motors Market has witnessed robust growth in recent years, driven by growing environmental concerns, the need for sustainable transportation, and urban mobility challenges. As cities around the world face issues such as pollution, traffic congestion, and rising fuel costs, electric bicycles (E-bikes) have emerged as a cost-effective, clean, and health-promoting mobility solution. The motor, being the heart of an E-Bike, is vital in…

Nerf Bars and Running Boards Market Predicted to Grow Substantially by 2032 - Pe …
Nerf Bars and Running Boards Market: A Growing Automotive Segment
As SUVs and pickup trucks become increasingly prevalent on global roads, the Nerf Bars and Running Boards Market has experienced significant growth. These accessories are essential for enhancing vehicle accessibility, especially for passengers with limited mobility such as elderly individuals and children. The market is driven not only by utility but also by growing consumer interest in vehicle aesthetics and customization.…
More Releases for Adrenocortical
Adrenocortical Hormones API Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Adrenocortical Hormones API market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Adrenocortical Hormones APImarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Adrenocortical Hormones APImarket, market definition, overview, industry opportunities…
Adrenocortical Hormones API Industry Outlook and Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Adrenocortical Hormones API industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Adrenocortical Hormones API and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
The recent report added by GLOBAL INFO RESEARCH gives a detailed account of the drivers and restraints in the global Adrenocortical Hormones API market. The research report,…
Adrenocortical Carcinoma Therapeutics - Pipeline Analysis 2018, Clinical Trials …
Adrenocortical carcinoma, also known as adrenal cortex carcinoma, is a rare form of cancer that occurs at the cortex layer of the adrenal gland. There are two adrenal glands present in the human body: one at the top of each kidney.
Download the sample report @ https://www.pharmaproff.com/request-sample/1109
Each adrenal gland is comprised of two distinct structures: the outer part of the adrenal glands (adrenal cortex) and the inner region (adrenal medulla). Some…
Adrenocortical Carcinoma Epidemiology: Genetic History of Carney Complex a Proba …
Characterized by cancerous growth in adrenal glands, adrenocortical carcinoma is identified as a rare disease, affecting children and adult alike. However, lack of symptoms at early stages hampers prognosis, thus encouraging significant advancement in adrenocortical carcinoma therapeutics. A new business intelligence report titled, 'Adrenocortical Carcinoma-Market Insights, Epidemiology and Market Forecast-2027' included in the vast online data archive of Market Research Hub (MRH) identifies current market developments and their reciprocal implications…
Adrenocortical Carcinoma Treatment Market to Witness Comprehensive Growth by 202 …
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer…
Adrenocortical Carcinoma Treatment Market Opportunities and Forecasts, 2017 – …
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer…